Development Of the VAMPCT Score for Predicting Mortality in CKD Patients with COVID-19
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.111558 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Chaofan Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research C…. Hauptthemen laut MEDLINE: COVID-19, Renal Insufficiency, Chronic. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) patients with coronavirus disease 2019 (COVID-19) are at significant risk of death. However, clinical identification of high-risk individuals remains suboptimal despite the recognition of many pathophysiological and comorbidity-related risk factors. We aim to develop a clinically simple machine learning (ML)-based score to predict acute COVID-19 mortality among CKD patients.
Methods
CKD inpatients with COVID-19 were prospectively enrolled from December 2022 to January 2023 with a three-month follow-up. Feature selection from clinical and laboratory results was performed through least absolute shrinkage and selection operator and stepwise selection. Logistic regression, support vector machine (SVM), random forest, and extreme gradient boosting were applied for ML model development. A predictive score for mortality was constructed using logistic regression. We compared predictive ability between the proposed score and other published scores.
Results
219 CKD patients were included and had a high mortality rate of 25.1%. The SVM model exhibited the best performance, with the validation area under the receiver operating characteristic curve (AUC) being 0.946 (95% CI 0.918, 0.974). The COVID-19 vaccination status, age, monocyte percentage, prothrombin activity, cardiac troponin T, and total bilirubin ("VAMPCT") were the most relevant factors and utilized to develop the scoring system with an AUC of 0.960 (95% CI 0.935, 0.985).
Conclusion
ML models predicting three-month mortality had favorable performance for CKD patients with COVID-19. The VAMPCT mortality score provided a user-friendly approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Medical Devices a…
- Department of Endocrine, Hebei General Hospital, Hebei 050051, China.
- Department of Urology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Li, C., Niu, Y., Pan, X., Chen, D., Liu, F., Feng, Z., Wang, Y., Cao, X., Wu, J., Liu, J., Guan, X., Sun, X., Zhang, L., Cai, G., Chen, X., & Li, P. (2025). Development Of the VAMPCT Score for Predicting Mortality in CKD Patients with COVID-19. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.111558
Vancouver
Li C, Niu Y, Pan X, Chen D, Liu F, Feng Z, et al. Development Of the VAMPCT Score for Predicting Mortality in CKD Patients with COVID-19. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.111558
BibTeX
@article{Li2025,
author = {Li, Chaofan and Niu, Yue and Pan, Xinyan and Chen, Dinghua and Liu, Fei and Feng, Zhe and Wang, Yong and Cao, Xueying and Wu, Jie and Liu, Jiabao and Guan, Xin and Sun, Xuefeng and Zhang, Li and Cai, Guangyan and Chen, Xiangmei and Li, Ping},
title = {Development Of the VAMPCT Score for Predicting Mortality in CKD Patients with COVID-19},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.111558}
}
EUVIMED